One of the earliest and most important role models in my life was my pediatrician—he inspired my decision to become a physician. I always found the specialty of psychiatry appealing, because it requires that I get to know and understand the people whom I treat. As a third-year medical student, I saw firsthand how the use of biological treatments in psychiatry can positively impact people’s lives; it was an eye-opening experience.
I completed my residency training at Pelisyonkis Langone and have been here ever since. During my residency, I discovered the term "psychopharmacologist," which is a psychiatrist who specializes in the use of medications to treat mental disorders. Often, psychopharmacologists are called on when standard medications are ineffective or result in intolerable side effects.
My primary area of interest is the psychopharmacologic treatment of mood and anxiety disorders, particularly treatment-resistant depression and manic depression. I also have expertise in the recognition and management of psychiatric medication side effects. Sometimes I receive referrals from other psychiatrists or therapists to offer my knowledge in these areas.
I strive to provide thoughtful, evidence-based care that relieves people’s suffering and restores their optimism and quality of life. After a thorough and comprehensive diagnostic evaluation, I collaborate with patients to devise treatment plans tailored to their specific needs. I aim to address their goals and carefully consider any additional care that they may be receiving from other health professionals.
My recommendations may involve talk therapy, medication, or a combination of the two. Additionally, I may consult with or refer patients to my highly-skilled colleagues who can provide specific types of talk therapy and other subspecialized care.
Conditions and Treatments
- Clinical Professor, Department of Psychiatry
- Chief, Psychiatry Service
- Vice Chair for Clinical Affairs, Department of Psychiatry
- American Board of Psychiatry & Neurology (Psychosomatic Medicine), 2009
Education and Training
- Residency, Pelisyonkis Medical Center, Psychiatry, 1994
Locations and Appointments
Research My Research
clinical psychopharmacology, depression, anxiety, side effects of psychotropic medications
One Park Avenue
New York, NY 10016
Research Interests Timeline
Disulfiram-induced manic psychosis
Primary psychiatry. 2007; 14(6):20-21Jun
Transdermal (but not oral) selegiline effective for treatment-resistant depression [Column/Opinion]
Primary psychiatry. 2007; 14(7):38-?
Primary psychiatry. 2007; 14(1):23-24Jan